Human Renal Cell Carcinoma Cell 786-O Transfection Kit

Description

The most common kind of kidney cancer, renal cell carcinoma, currently has no known cause. Established human cell lines can be used as test subjects for novel kidney cancer therapies, helping researchers better understand the epidemiology of the illness and the range of therapeutic options. The original clear cell adenocarcinoma cells utilized to establish the 786-O cell line were obtained from the renal cell adenocarcinoma of a 58-year-old Caucasian male patient. This cell line exhibits epithelial cell shape and produces parathyroid hormone (PTH). In addition to serving as a good transfection host, the 786-O cell line is essential for studying human infections related to the prostate as well as for research into prostate cancer. CD BioSciences provides biodegradable polymer-based transfection reagents for the 786-O cell line.